Kuraray assuming oil price rise to $200 in new business plan

Kuraray assuming oil price rise to $200 in new business plan

TOKYO, Japan - Fumio Ito, president of Kuraray Co., speaks at an interview with Kyodo News in Tokyo. Ito said the major Japanese chemicals maker will pursue a double-digit sales increase under a new medium-term business plan even if crude oil prices shoot up to $200 per barrel. (Kyodo)

  • Product Code
  • ILEA000039653
  • Registered date
  • 2008/7/08 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1303 × 1763 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 535.76(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    Honda to cut EV investment plan by 30%

    TOKYO, Japan, May 20 Kyodo - Honda Motor Co. President Toshihiro Mibe attends a press conference on the company's electrification strategy in Tokyo on May 20, 2025, announcing a plan to curtail its investment in electric vehicle technology through fiscal 2030 by 30 percent from the initial plan. (Kyodo)

      Honda, Nissan eye merger

      TOKYO, Japan, Dec. 18 Kyodo - Combined photo taken from a Kyodo News helicopter on Dec. 18, 2024, shows the headquarters of Honda Motor Co. (L) in Tokyo and Nissan Motor Co. in Yokohama, near Tokyo. The two major Japanese automakers are in talks on the possible establishment of a holding company in a bid to form a global alliance to challenge foreign electric vehicle makers, a source familiar with the deal said the same day. (Kyodo)

        Honda, Nissan eye merger

        TOKYO, Japan, Dec. 18 Kyodo - The two major Japanese automakers are in talks on the possible establishment of a holding company in a bid to form a global alliance to challenge foreign electric vehicle makers, a source familiar with the deal said on Dec. 18, 2024. (Kyodo)
          TOSHIBA CORPORATION New Mid-term Business Plan Presentation

          TOSHIBA CORPORATION New Mid-term Business Plan Presentation

          TOSHIBA CORPORATION Presentation of the new medium-term management plan. Photo shows TOSHIBA’s President Taro Shimada. ＝May 16, 2024, Tokyo, Japan
            TOSHIBA CORPORATION New Mid-term Business Plan Presentation

            TOSHIBA CORPORATION New Mid-term Business Plan Presentation

            TOSHIBA CORPORATION Presentation of the new medium-term management plan. Photo shows, from left, TOSHIBA’s President Taro Shimada and Vice President Koji Iketani. ＝May 16, 2024, in Tokyo, Japan
              TOSHIBA CORPORATION New Mid-term Business Plan Presentation

              TOSHIBA CORPORATION New Mid-term Business Plan Presentation

              TOSHIBA CORPORATION Presentation of the new medium-term management plan. Photo shows, from left, TOSHIBA’s President Taro Shimada and Vice President Koji Iketani. ＝May 16, 2024, in Tokyo, Japan

                Daihatsu unveils new management policy after testing scandal

                TOKYO, Japan, April 8 Kyodo - Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. (Kyodo)
                  Shionogi's new mid-term management plan briefing

                  Shionogi's new mid-term management plan briefing

                  On the 1st, Shionogi announced a new mid-term management plan to invest 500 billion yen in expanding overseas business and launching new businesses by FY2024. The company will also increase research and development expenses by 20% over the past five years to about 342.1 billion yen. In addition to strengthening its own sales of pharmaceuticals in Japan and overseas, the company will also invest heavily in products and services other than ethical drugs, such as vaccines.In terms of sales strategy, the company plans to strengthen its sales in the U.S. and China, and increase the ratio of overseas sales to more than 50% in FY2012 (18.5% in FY2007). President Tedairogi said, "We aim to become a drug discovery company that people from outside the company want to work with," and also indicated that the company will place importance on alliance strategies. (Photo taken on June 1, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                    In-train spraying of antiviral materials by JR West

                    In-train spraying of antiviral materials by JR West

                    West Japan Railway Co. (JR West) has begun anti-viral and anti-bacterial treatment of the entire interior of its trains, with plans to implement the treatment on about 3,600 cars running in the Keihanshin area by the end of September and eventually on all 5,200 cars on conventional lines. The plan is to ensure the safety and security of passengers under with corona. The system uses chemicals that have been confirmed by a third-party organization to be effective against influenza and noroviruses. The effect will last for several years, the company said. The chemicals will be sprayed on windows, seats and other places where passengers may touch them. The number of commuters and other passengers in the Kansai region is gradually returning following the lifting of the state of emergency declared for the new coronavirus infection on March 21. Kazuaki Hasegawa, president of the company, said, Photo taken on May 22, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images
                      Japan Post Group chiefs

                      Japan Post Group chiefs

                      Japan Post Holdings Co. President Masatsugu Nagato (C), Japan Post Insurance Co. President Mitsuhiko Uehira (R) and Japan Post Co. President Kunio Yokoyama attend a press conference in Tokyo on Dec. 27, 2019. Japan Post Holdings announced the three will resign to take responsibility for the scandal involving a huge number of faulty sales of insurance products. (Kyodo) ==Kyodo